@keckschoolusc: Big news in Alzheimer's research! 🧠 Lecanemab (#Leqembi), a drug shown to slow down Alzheimer’s disease, received full approval from the FDA. Paul Aisen, MD, the founding director of the Alzheimer’s Therapeutic Research Institute is co-leading the AHEAD study of the drug in pre-symptomatic Alzheimer’s.

Keck School of Medicine of USC

Open In TikTok:

Region: US

Thursday 06 July 2023 23:09:35 GMT